THUSEL-212: Enhanced Serum Uric Acid Control in Hyperuricemic Patients through Selective Mitigation of Anti-Drug Antibodies against Pegsiticase Center for Clinical Research, Altoona, PA

First Page		Document Content
Date: 2017-12-21 11:46:52		THUSEL-212: Enhanced Serum Uric Acid Control in Hyperuricemic Patients through Selective Mitigation of Anti-Drug Antibodies against Pegsiticase Center for Clinical Research, Altoona, PA Add to Reading List Source URL: selectabio.com Download Document from Source Website File Size: 573,03 KB Share Document on Facebook